Latest News

If you are wondering whether Magnolia Oil & Gas is attractively priced today, the key question is how its current share price lines up with its underlying business value. The stock closed at US$22.21 most recently, with returns of 1.5% over the last 7 days, a 2.8% decline over 30 days, a 1.2% decline year to date, a 6.1% decline over 1 year, a 0.2% gain over 3 years, and a 172.0% gain over 5 years. Recent coverage of Magnolia Oil & Gas has focused on its share price performance over...

Halozyme Therapeutics (HALO) has been in focus after a new collaboration with Skye Bioscience to apply its ENHANZE drug delivery technology to nimacimab, an investigational obesity treatment, as the company expands into metabolic disease. See our latest analysis for Halozyme Therapeutics. The new Skye Bioscience collaboration and December 2025 ENHANZE agreement with Takeda come as Halozyme’s 1 month share price return of 16.58% and 90 day share price return of 12.53% suggest improving...

Aeva Technologies (AEVA) is back in the spotlight after two CES-linked announcements, including NVIDIA’s adoption of its 4D LiDAR for the DRIVE Hyperion platform and the debut of the Omni sensor for physical AI applications. See our latest analysis for Aeva Technologies. Aeva’s recent CES news arrives after a period of sharp swings, with a 7 day share price return of 27.18% and a 1 year total shareholder return above 200%. However, the 5 year total shareholder return remains deeply negative,...

Kenvue has appointed Madhav Nayak as Vice President and Chief Marketing Officer for the Asia-Pacific region, drawing on his prior leadership roles at Yum! Brands, Meta, and Unilever across marketing, strategy, digital, and commercial functions. By bringing in a CMO with deep experience building global consumer brands in Asia, Kenvue is signaling a stronger push to sharpen its marketing and digital execution in one of its most important growth regions. Next, we’ll explore how Nayak’s...

Recent broker attention on City Developments (SGX:C09) has focused on its asset sales program, including the agreed disposal of Quayside Isle @ Sentosa Cove at about 47% above book value, alongside discussion of a potential strategic review. See our latest analysis for City Developments. Those asset disposals and talk of a broader review are landing in a period of strong momentum, with a 30 day share price return of 22.68% and a 1 year total shareholder return of 77.58%. This suggests...

Endeavour Silver Corp. reported its full-year 2025 output at 6,486,661 ounces of silver, 37,164 ounces of gold and 11.2 million silver-equivalent ounces, reflecting the addition of Kolpa and the October 2025 start of commercial production at the Terronera mine. Beyond the headline growth in volumes, the company’s decision to ramp Terronera through lower-grade zones before moving into higher-grade areas in 2026 highlights a phased approach to building sustainable production. We’ll now examine...

In early January 2026, Moderna reported positive Phase 3 data and submitted regulatory applications in the U.S., EU, Canada, and Australia for its mRNA-1010 seasonal flu vaccine for adults aged 50 and over. This move highlights Moderna’s effort to broaden its respiratory vaccine lineup beyond COVID-19, aiming to reduce dependence on a single product category and make fuller use of its mRNA platform. We’ll now examine how this progress on mRNA-1010, and its potential to diversify respiratory...

In early January 2026, SPS Commerce, Inc. announced a suite of new products and AI-enabled capabilities, including direct SAP S/4HANA cloud integrations and Shopify system automation, to improve real-time visibility and coordination across complex, omnichannel retail supply chains. The launch of the SPS Commerce Relationship Center and Manufacturing Suite is especially material, as it targets the growing need to onboard new partners efficiently and manage diversified, multi-tier supply...

Hawaiian Electric Industries (HE) has reached preliminary agreements to resolve eight shareholder lawsuits tied to alleged wildfire risk disclosure failures, planning to use US$100 million in insurance proceeds without admitting wrongdoing. See our latest analysis for Hawaiian Electric Industries. The settlement news lands after a sharp shift in sentiment, with the share price at US$13.66 and a 90 day share price return of 25.44% alongside a 1 year total shareholder return of 53.31%. However,...

Why PUMA (XTRA:PUM) is on investors’ radar today PUMA (XTRA:PUM) has attracted attention after recent share price moves, with the stock showing mixed return patterns across the past week, month and past 3 months that may prompt a closer look. See our latest analysis for PUMA. That recent 30 day share price return of 18.65% and 90 day share price return of 12.62% sit against a 1 year total shareholder return decline of 42.14%. This suggests short term momentum has picked up while longer term...

Carpenter Technology (CRS) is back in focus as investors weigh its role in supplying specialty alloys to aerospace, defense, and industrial customers, with interest tied to themes such as re-arming and reshoring manufacturing. See our latest analysis for Carpenter Technology. After a sharp run that has drawn fresh attention to its aerospace and defense exposure, Carpenter Technology’s shares now trade at US$321.26, with a 90 day share price return of 33.25% and a 1 year total shareholder...

Delivery Hero SE has appointed Chief Product Officer Johannes Bruder to its Management Board, effective January 1, 2026, reinforcing leadership around its unified global technology platform that links customers, vendors, and riders across markets. This move elevates technology and AI-driven automation to the core of board-level decision-making, underlining how product leadership is central to Delivery Hero’s efforts to scale efficiently while keeping user experiences localized and...

Arcus Biosciences recently outlined its 2026 priorities, including multiple planned data readouts for casdatifan in clear cell renal cell carcinoma and ongoing development of quemliclustat for first-line pancreatic cancer. An interesting angle for investors is how Arcus is positioning casdatifan through both early- and late-line trials as part of a "fast-to-market" approach in kidney cancer while also building an emerging inflammation and immunology franchise. Next, we’ll examine how this...

Why LGI Homes Is On Investors’ Radar Today LGI Homes (LGIH) has been drawing fresh attention as investors reassess the US homebuilder’s share performance, business mix, and recent financial metrics, including revenue, earnings, and longer term total returns. See our latest analysis for LGI Homes. After a sharp 8.4% 1 day share price return to around $46.77 and a 7 day share price return of 8.9%, LGI Homes is showing short term momentum. However, its 1 year total shareholder return of around a...

In recent days, Zillow released its latest Consumer Housing Trends Report and hottest markets forecast, highlighting that nearly three in five renters expect to keep renting in 2026 and that Hartford is projected to see the strongest home price growth with tight inventory conditions. These findings suggest that lifestyle-driven renting and concentrated demand in select markets like Hartford could reshape how households use Zillow’s platforms and services. Next, we'll examine how the rise of...

RBC Capital Markets recently highlighted Constellation Software as one of its top Canadian technology ideas for 2026, citing sector-wide expectations for solid revenue and adjusted EBITDA growth. Alongside this upbeat sector view, investors also learned more about insider ownership and a recent executive share transaction, adding context to how management is aligned with shareholders. Next, we’ll examine how RBC’s favourable view on Canadian technology growth influences Constellation...

If you are wondering whether Resideo Technologies is priced attractively or already baking in high expectations, you are in the right place. The stock last closed at US$36.86, with returns of 5.0% over 7 days, 9.8% over 30 days, 4.8% year to date, 63.4% over 1 year, 98.2% over 3 years, and 44.5% over 5 years, which raises fair questions about how much value is now reflected in the share price. Recent coverage has focused on Resideo's position in residential comfort, security and energy...

If you are wondering whether Cadence Bank's current share price offers good value or not, you are in the right place because this article focuses squarely on what investors may be paying for today. Cadence Bank's stock has recently closed at US$45.67, with returns of 6.6% over 7 days, 9.7% over 30 days, 5.7% year to date, 34.3% over 1 year and 76.9% over 5 years. This raises questions about how much of this performance is already reflected in the price. Recent attention on Cadence Bank has...

If you are wondering whether Polaris is fairly priced or has room to run, you are not alone. This article will walk you through what the current valuation signals are really saying. The stock last closed at US$73.60, with returns of 16.4% over the past 7 days, 9.9% over 30 days, 10.7% year to date, 40.2% over 1 year, and longer term returns of a 23.3% decline over 3 years and a 19.6% decline over 5 years, pointing to a mixed picture for investors. Recent attention on Polaris has been shaped...

ANI Pharmaceuticals recently announced that CEO Nikhil Lalwani would present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with the session available via live and archived webcast on the company’s website for 30 days. This conference appearance comes as ANI’s rare disease portfolio, including Cortrophin Gel and acquired ophthalmology products, underpins strong recent financial performance and growing investor attention. Now we’ll examine how robust 2025 results in...

FactSet Research Systems recently filed its latest Form 10-Q, outlining its recent financial and operational performance across the Americas, EMEA, and Asia Pacific segments. The filing highlights how FactSet is weaving AI-powered tools more deeply into its platform to enhance client insights and streamline workflows worldwide. Next, we’ll explore how FactSet’s expanded AI integration within its platform could influence the company’s existing investment narrative and outlook. We've found 11...

Colgate-Palmolive (India) Limited's ( NSE:COLPAL ) price-to-earnings (or "P/E") ratio of 42x might make it look like a...

Key Insights Stockland's significant retail investors ownership suggests that the key decisions are influenced by...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...